Almetra
Manufacturing software that combines production video, machine data and operator feedback to explain losses and guide improvements.
€16.3MSeries A
Role not disclosedMC
Merantix Capital
Activity from announced rounds
Activity in this selectionJun 30, 2026 · AI · Jun 1, 2026
- Rounds participated in
- 3
- Confirmed lead rounds
- — 3 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $24.6M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionGraph Therapeutics
Develops precision medicines for inflammatory and immune-mediated diseases using AI-powered patient cell analysis
$5MSeries A
Role not disclosedWhyBrilliant
Develops AI-powered recruitment platform for professionals and companies
€1MPre-Seed
Role not disclosed